Matthew Price

Matthew Price is the founder of Phosplatin Therapeutics. Phosplatin Therapeutics has raised $74M in total funding. Latest round: Series A.

About Matthew Price

Matthew Price is a co-founder and Chief Operating Officer (COO) of Phosplatin Therapeutics (now Promontory Therapeutics), a clinical-stage biotech company focused on oncology therapeutics. He has led the company's funding strategy, which has included raising $74 million in equity capital.

Matthew Price at a glance

More founders in New York City, United States (44)

Browse related founder lists (3)

Full founder directory · Investor directory · Company funding database · Fundraising library